Plain-English translation of NCT07474519 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 4 โ The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This study is testing whether your body position during BCG treatment โ a standard therapy for non-muscle-invasive bladder cancer โ makes a difference in how well it works. You'll receive your regular treatment three times, but each time you'll be asked to stay in a different position (no restrictions the first time, lying down the second time, and sitting the third time) to see if position affects how long the medicine stays in your bladder.
Doctors want to know if simple changes like body position can help this treatment work better for bladder cancer patients. There's a theory that keeping the medicine in contact with the bladder for longer might improve outcomes, and position might help with that.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
You'll come to the clinic once a week for three weeks to receive your standard treatment. The first week, you'll get the treatment and then go home with no activity restrictions. The second week, you'll stay lying down for as long as you can (up to 2 hours) before going home. The third week, you'll stay sitting upright for as long as you can (up to 2 hours) before going home. Throughout the study, you'll wear a fitness tracker to monitor your activity and vital signs, and you may have remote check-ins with the research team by phone or video.
AI-generated summary from trial data ยท Jun 7, 2026 ยท Not medical advice
United States